Menu

Blog

Archive for the ‘healthspan’ tag: Page 13

Nov 1, 2016

Who wants to live forever?

Posted by in categories: aging, bioengineering, cryonics, disruptive technology, DNA, futurism, genetics, health, life extension, posthumanism

Bioquark Inc. (www.bioquark.com) Interview in MoneyWeek

bioquarklogo

Read whole story: http://moneyweek.com/who-wants-to-live-forever/

Oct 25, 2016

10 companies that want to make chemotherapy easier for patients — Bioquark Inc.

Posted by in categories: aging, bioengineering, biological, biotech/medical, disruptive technology, DNA, genetics, health, life extension, science
Bioquark Inc. (www.bioquark.com) mention on CNBC — the best way to make chemo easier is to eliminate the need for it forever!

Continue reading “10 companies that want to make chemotherapy easier for patients — Bioquark Inc.” »

Aug 2, 2016

Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare

Posted by in categories: aging, bioengineering, biotech/medical, DNA, health, life extension, neuroscience, posthumanism, science, transhumanism

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

regenerage

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

Continue reading “Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare” »

Mar 9, 2016

Death Reversal — The Reanima Project — Research Whose Time Has Come

Posted by in categories: aging, biotech/medical, business, cryonics, health, life extension, neuroscience, posthumanism, science, scientific freedom

I have spent the last 30 years in various aspects of the biopharmaceutical industry, which for the most part has been a very rewarding experience.

However, during this time period, having been immersed many different components of therapeutic development and commercialization, one thing has always bothered me: a wide array of promising research never makes it off the bench to see the translational light of day, and gets lost in the historical scientific archives.

bqiinclab

I always believed that scientific progress happened in a very linear narrative, with each new discovery supporting the next, resulting ultimately in an eventual stairway of scientific enlightenment.

Continue reading “Death Reversal — The Reanima Project — Research Whose Time Has Come” »

Page 13 of 13First678910111213